Advancing breast cancer therapy in the era of molecular diagnostics

Advancing breast cancer therapy in the era of molecular diagnostics

Advances in cancer biology and drug development now enable treatments tailored to individual tumor profile. Targeting specific molecular alterations marked a significant step forward in cancer care, including breast cancer. Access to these therapies is improving thanks to the implementation of molec...

Full description

Saved in:

Bibliographic Details
Main Authors:	Maria Grazia Carnevale, Riccardo Ray Colciago, Maria Carmen De Santis, Laura Cortesi, Cinzia De Marco, Antonio Marra, Andrea Vingiani, Franco Nolè, Giuseppe Curigliano, Giancarlo Pruneri, Antonio Llombart-Cussac, Serena Di Cosimo, Javier Cortes
Format:	Article
Language:	English
Published:	Elsevier 2025-08-01
Series:	Breast
Subjects:	Breast cancer Biomarkers Mutations Targeted therapy Molecularly-informed therapy Precision medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S0960977625005053
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SPECTRUM OF SOMATIC MUTATIONS IN RETROPERITONEAL LEIOMYOSARCOMA: CLINICAL CASE AND LITERATURE REVIEW
by: V. E. Bugaev, et al.
Published: (2020-09-01)

Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review
by: Lucía Serrano García, et al.
Published: (2024-12-01)

Molecular pathology of lung cancer: clinical aspects
by: I. S. Polyakov, et al.
Published: (2016-02-01)

Osteogenesis Imperfecta: A Narrative Review of Pathogenesis, Clinical Manifestations and Emerging Therapies
by: Prashanth Balusani, et al.
Published: (2025-05-01)

DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES
by: Prof. Giuseppe Leone, et al.
Published: (2022-04-01)

New therapeutic approaches for EGFR mutated non-small cell lung cancer on osimertinib era
by: Jaime Rubio-Perez, et al.
Published: (2025-01-01)

Factors Influencing Late Breast Toxicity After Radiotherapy: A Scoping Review
by: Riccardo Ray Colciago, et al.
Published: (2025-05-01)

Contribution of Genetic Causes in Ear Vestibular Disorders
by: Y Lotfi, et al.
Published: (2024-12-01)

Mitochondrial changes in carcinogenesis as a goal of antitumor therapy (review)
by: T. E. Potemina, et al.
Published: (2020-12-01)

The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco
by: Khadija Bakhouch, et al.
Published: (2009-06-01)

Genetic Counselling, Testing, and Management of Hereditary Breast and Ovarian Cancer Syndrome in India: Updated Expert Consensus Recommendations from Indian Society of Medical and Pediatric Oncology
by: Hemant Malhotra, et al.
Published: (2025-06-01)

Molecular diagnostics in clinical oncology: an overview
by: Evgeny Imyanitov, et al.
Published: (2025-07-01)

ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapy
by: Konstantinos Venetis, et al.
Published: (2025-05-01)

TREATMENT OF <em>BRAF</em><sup>V600E</sup> POSITIVE ANAPLASTIC THYROID CARCINOMA: CASE REPORT
by: P. A. Nikiforovich, et al.
Published: (2020-10-01)

Proton therapy for adult type IDH-mutated glioma: Proglio-1, a multicenter retrospective study
by: Nicolas Goliot, et al.
Published: (2025-08-01)

An 8-year-old girl with secondary histiocytic sarcoma with BRAFV600 mutation following T-cell acute lymphoblastic leukemia demonstrating stable disease for 3 years on dabrafenib and trametinib – a case report and literature review
by: Sue Lyn Tan, et al.
Published: (2025-03-01)

Notch signaling in cancers: mechanism and potential therapy
by: Chen Chen, et al.
Published: (2025-02-01)

Vorasidenib for IDH-mutant grade 2 gliomas: clinical advances and future directions
by: Zhenjiang Pan, et al.
Published: (2025-06-01)

Systemic therapy of skin metastatic melanoma with BRAF gene mutation
by: Yu. S. Shakh-Paronyants, et al.
Published: (2023-03-01)

Differential Responses to Targeted Therapies in Non-Small Cell Lung Cancer: A Comparative Analysis of Outcomes in Patients with Single EGFR Mutation and Concurrent Gene Alterations
by: Le LT, et al.
Published: (2025-07-01)

Emergence of IGH::CCND1 rearrangement and mutations in TP53, BTK, and BCL2 associated with therapy resistance in chronic lymphocytic leukemia
by: Qing Wei, et al.
Published: (2024-12-01)

Time to Next Treatment Following Sub-Ablative Progression Directed Radiation Therapy for Oligoprogressive Non-Small-Cell Lung Cancer
by: Riccardo Ray Colciago, et al.
Published: (2024-11-01)

Comprehensive Survey of AACR GENIE Database of Tumor Mutation Burden (TMB) Among All Three Classes (I, II, III) of BRAF Mutated (BRAF+) NSCLC
by: Arter ZL, et al.
Published: (2025-02-01)

Severe Aplastic Anemia Complicated with Fatal Invasive Fungal Infections in a Young Patient Harboring Perforin Gene Polymorphisms
by: Maria I. Krithinaki, et al.
Published: (2025-05-01)

Real‐World Prevalence, Treatment Patterns, and Outcomes for Patients With HER2 (ERBB2)‐Mutant Metastatic Non‐Small Cell Lung Cancer, From a US‐Based Clinico‐Genomic Database
by: Sarah Waliany, et al.
Published: (2024-12-01)

Response to crizotinib in advanced intrahepatic cholangiocarcinoma with ZKSCAN1-MET fusion and MET amplification: case reports and literature review
by: Jian-Hui Wu, et al.
Published: (2025-06-01)

Case Report: Heterozygous out-of-frame frameshift variant in ELANE without evidence of neutropenia
by: Yulin Li, et al.
Published: (2025-07-01)

Molecular genetic studies of glial tumors in children
by: P. S. Soltan, et al.
Published: (2016-12-01)

Drugging the ‘undruggable’ KRAS: breakthroughs, challenges, and opportunities in pancreatic cancer
by: Nawaz Khan, et al.
Published: (2025-07-01)

Neonatal diabetes mellitus due to a new KCNJ11 mutation - 10 years of the patient`s follow-up
by: Maja D Ješić, et al.
Published: (2021-06-01)

An exosome-based nanoplatform for siRNA delivery combined with starvation therapy promotes tumor cell death through autophagy, overcoming refractory KRAS-mutated tumors and restoring cetuximab chemosensitivity
by: Yurong Xiang, et al.
Published: (2025-06-01)

HIV drug resistance and its associated factors among patients during interruption of antiretroviral therapy in China
by: Zhongbao Zuo, et al.
Published: (2025-07-01)

Braf-Mutant Melanomas: Biology and Therapy
by: Elvira Pelosi, et al.
Published: (2024-12-01)

Real-life evidence of encorafenib plus binimetinib in patients with unresectable advanced or metastatic BRAFV600-mutant melanoma in Spain: the BECARE (GEM-2002) trial
by: Ainara Soria, et al.
Published: (2025-02-01)

De Novo EGFR ‐ALK and EGFR ‐ROS1 Co‐Mutations in NSCLC: Clinical Characteristics, Molecular Profiling, and Treatment Outcomes From a Retrospective Analysis
by: Lili Shen, et al.
Published: (2025-08-01)

Immune Escape and Drug Resistance Mutations in Patients with Hepatitis B Virus Infection: Clinical and Epidemiological Implications
by: Maria Antonia De Francesco, et al.
Published: (2025-04-01)

LYN kinase and estrogen receptor ERα: involvement in carcinogenesis and potential therapeutic target for tumors
by: V. V. Tikhonova, et al.
Published: (2021-11-01)

Infantile Pompe disease: Clinical picture, diagnosis, and treatment
by: N. P. Kotlukova, et al.
Published: (2015-02-01)

Malignant catatonia in an adolescent with pogo transposable element derived with zinc finger domain (POGZ) gene mutation: case report
by: Liron Leibovitch, et al.
Published: (2025-09-01)

Mutational profile of KRAS-positive colorectal cancer
by: E. N. Telysheva, et al.
Published: (2022-03-01)